PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) HETERODIMERS REDUCE SERUM LDL-CHOLESTEROL (LDL-C) LEVELS IN MAINTENANCE HEMODIALYSIS (HD) PATIENTS ASSOCIATED WITH DYSLIPIDEMIA CHARACTERIZED BY INCREASED TRIGLYCERIDE-RICH LIPOPROTEINS

被引：0
|
作者：
Kihara, Emi [1 ]
Arita, Kazuko [1 ]
Hamamoto, Misuzu [1 ]
Maeda, Katsutoshi [1 ]
Oda, Hiroaki [1 ]
Doi, Shigehiro [2 ]
Masaki, Takao [2 ]
机构：
[1] Oda Med Clin, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Dept OF Nephrol, Hiroshima, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 35 条
  • [1] THE IMPACT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ON SERUM LIPID PROFILE IN HEMODIALYSIS (HD) PATIENTS
    Arita, Kazuko
    Tanabe, Takehiro
    Kihara, Emi
    Maeda, Katsutoshi
    Oda, Hiroaki
    Doi, Shigehiro
    Masaki, Takao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 293 - 293
  • [2] LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
    Sabatel-Perez, F.
    Garcia-Ropero, A.
    Santos-Gallego, G.
    Zafar, M. Urooj
    Badimon, J. J.
    DRUGS OF TODAY, 2019, 55 (05) : 329 - 344
  • [3] Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
    Baragetti, Andrea
    Grejtakova, Daniela
    Casula, Manuela
    Olmastroni, Elena
    Jotti, Gloria Saccani
    Norata, Giuseppe Danilo
    Catapano, Alberico L.
    Bellosta, Stefano
    PHARMACOLOGICAL RESEARCH, 2018, 130 : 1 - 11
  • [4] Beyond LDL-C lowering: Distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency
    Janis, Minna T.
    Tarasov, Kirill
    Ta, Hung Xuan
    Suoniemi, Matti
    Ekroos, Kim
    Hurme, Reini
    Lehtimaki, Terho
    Paiva, Hannu
    Kleber, Marcus E.
    Maerz, Winfried
    Prat, Annik
    Seidah, Nabil G.
    Laaksonen, Reijo
    ATHEROSCLEROSIS, 2013, 228 (02) : 380 - 385
  • [5] Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target
    Guijarro, Carlos
    Miguel Ruilope, Luis
    MEDICINA CLINICA, 2015, 145 (02): : 67 - 69
  • [6] Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism
    Chan, Dick C.
    Watts, Gerald F.
    Somaratne, Ransi
    Wasserman, Scott M.
    Scott, Rob
    Barrett, P. Hugh R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (07) : 1644 - 1655
  • [7] PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) ASSOCIATION TO LDL IN PATIENTS TREATED WITH ANTI-PCSK9 MONOCLONAL ANTIBODIES.
    Canclini, L.
    Jabnati, N.
    Malvandi, A. M.
    Baragetti, A.
    Grigore, L.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2021, 331 : E139 - E139
  • [8] Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease
    Nozue, Tsuyoshi
    Hattori, Hiroaki
    Ogawa, Kazuyuki
    Kujiraoka, Takeshi
    Iwasaki, Tadao
    Hirano, Tsutomu
    Michishita, Ichiro
    LIPIDS IN HEALTH AND DISEASE, 2016, 15 : 1 - 7
  • [9] Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease
    Tsuyoshi Nozue
    Hiroaki Hattori
    Kazuyuki Ogawa
    Takeshi Kujiraoka
    Tadao Iwasaki
    Tsutomu Hirano
    Ichiro Michishita
    Lipids in Health and Disease, 15
  • [10] Immunization against proprotein convertase subtilisin-like/kexin type 9 lowers plasma LDL-cholesterol levels in mice
    Fattori, Elena
    Cappelletti, Manuela
    Lo Surdo, Paola
    Calzetta, Alessandra
    Bendtsen, Claus
    Ni, Yan G.
    Pandit, Shilpa
    Sitlani, Ayesha
    Mesiti, Giuseppe
    Carfi, Andrea
    Monaci, Paolo
    JOURNAL OF LIPID RESEARCH, 2012, 53 (08) : 1654 - 1661
1234